These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 33080394
1. The antidiabetic drug glibenclamide exerts direct retinal neuroprotection. Berdugo M, Delaunay K, Naud MC, Guegan J, Moulin A, Savoldelli M, Picard E, Radet L, Jonet L, Djerada Z, Gozalo C, Daruich A, Beltrand J, Jeanny JC, Kermorvant-Duchemin E, Crisanti P, Polak M, Behar-Cohen F. Transl Res; 2021 Mar; 229():83-99. PubMed ID: 33080394 [Abstract] [Full Text] [Related]
3. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date. King ZA, Sheth KN, Kimberly WT, Simard JM. Drug Des Devel Ther; 2018 Mar; 12():2539-2552. PubMed ID: 30147301 [Abstract] [Full Text] [Related]
4. Glimepiride and glibenclamide have comparable efficacy in treating acute ischemic stroke in mice. Wang X, Chang Y, He Y, Lyu C, Li H, Zhu J, Liu K, Hu Y, Huang K, Pan S. Neuropharmacology; 2020 Jan 01; 162():107845. PubMed ID: 31704276 [Abstract] [Full Text] [Related]
5. Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage. Jiang B, Li L, Chen Q, Tao Y, Yang L, Zhang B, Zhang JH, Feng H, Chen Z, Tang J, Zhu G. Transl Stroke Res; 2017 Apr 01; 8(2):183-193. PubMed ID: 27807801 [Abstract] [Full Text] [Related]
10. SUR1-TRPM4 channels, not KATP, mediate brain swelling following cerebral ischemia. Woo SK, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Gerzanich V, Simard JM. Neurosci Lett; 2020 Jan 23; 718():134729. PubMed ID: 31899311 [Abstract] [Full Text] [Related]
11. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S. Eur J Pharmacol; 2001 Nov 09; 431(1):119-25. PubMed ID: 11716850 [Abstract] [Full Text] [Related]
12. Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations. Martin GM, Rex EA, Devaraneni P, Denton JS, Boodhansingh KE, DeLeon DD, Stanley CA, Shyng SL. J Biol Chem; 2016 Oct 14; 291(42):21971-21983. PubMed ID: 27573238 [Abstract] [Full Text] [Related]
13. Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM. Martin GM, Kandasamy B, DiMaio F, Yoshioka C, Shyng SL. Elife; 2017 Oct 24; 6():. PubMed ID: 29035201 [Abstract] [Full Text] [Related]
14. Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Simard JM, Tsymbalyuk O, Keledjian K, Ivanov A, Ivanova S, Gerzanich V. Exp Neurol; 2012 Jan 24; 233(1):566-74. PubMed ID: 22177998 [Abstract] [Full Text] [Related]
15. [Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin-induced diabetic rats]. Li Y, Deng Q, Fu Z. Zhonghua Yi Xue Za Zhi; 2000 Jul 24; 80(7):538-40. PubMed ID: 11798815 [Abstract] [Full Text] [Related]
17. Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition. Russ U, Kühner P, Prager R, Stephan D, Bryan J, Quast U. Br J Pharmacol; 2009 Jan 24; 156(2):354-61. PubMed ID: 19154434 [Abstract] [Full Text] [Related]